---
title: Combinatorial, additive and dose-dependent drug–microbiome associations
authors:
- Sofia K. Forslund
- Rima Chakaroun
- Maria Zimmermann-Kogadeeva
- Lajos Markó
- Judith Aron-Wisnewsky
- Trine Nielsen
- Lucas Moitinho-Silva
- Thomas S. B. Schmidt
- Gwen Falony
- Sara Vieira-Silva
- Solia Adriouch
- Renato J. Alves
- Karen Assmann
- Jean-Philippe Bastard
- Till Birkner
- Robert Caesar
- Julien Chilloux
- Luis Pedro Coelho
- Leopold Fezeu
- Nathalie Galleron
- Gerard Helft
- Richard Isnard
- Boyang Ji
- Michael Kuhn
- Emmanuelle Le Chatelier
- Antonis Myridakis
- Lisa Olsson
- Nicolas Pons
- Edi Prifti
- Benoit Quinquis
- Hugo Roume
- Joe-Elie Salem
- Nataliya Sokolovska
- Valentina Tremaroli
- Mireia Valles-Colomer
- Christian Lewinter
- Nadja B. Søndertoft
- Helle Krogh Pedersen
- Tue H. Hansen
- Chloe Amouyal
- Ehm Astrid Andersson Galijatovic
- Fabrizio Andreelli
- Olivier Barthelemy
- Jean-Paul Batisse
- Eugeni Belda
- Magalie Berland
- Randa Bittar
- Hervé Blottière
- Frederic Bosquet
- Rachid Boubrit
- Olivier Bourron
- Mickael Camus
- Dominique Cassuto
- Cecile Ciangura
- Jean-Philippe Collet
- Maria-Carlota Dao
- Morad Djebbar
- Angélique Doré
- Line Engelbrechtsen
- Soraya Fellahi
- Sebastien Fromentin
- Pilar Galan
- Dominique Gauguier
- Philippe Giral
- Agnes Hartemann
- Bolette Hartmann
- Jens Juul Holst
- Malene Hornbak
- Lesley Hoyles
- Jean-Sebastien Hulot
- Sophie Jaqueminet
- Niklas Rye Jørgensen
- Hanna Julienne
- Johanne Justesen
- Judith Kammer
- Nikolaj Krarup
- Mathieu Kerneis
- Jean Khemis
- Ruby Kozlowski
- Véronique Lejard
- Florence Levenez
- Lea Lucas-Martini
- Robin Massey
- Laura Martinez-Gili
- Nicolas Maziers
- Jonathan Medina-Stamminger
- Gilles Montalescot
- Sandrine Moute
- Ana Luisa Neves
- Michael Olanipekun
- Laetitia Pasero Le Pavin
- Christine Poitou
- Francoise Pousset
- Laurence Pouzoulet
- Andrea Rodriguez-Martinez
- Christine Rouault
- Johanne Silvain
- Mathilde Svendstrup
- Timothy Swartz
- Thierry Vanduyvenboden
- Camille Vatier
- Stefanie Walther
- Jens Peter Gøtze
- Lars Køber
- Henrik Vestergaard
- Torben Hansen
- Jean-Daniel Zucker
- Serge Hercberg
- Jean-Michel Oppert
- Ivica Letunic
- Jens Nielsen
- Fredrik Bäckhed
- S. Dusko Ehrlich
- Marc-Emmanuel Dumas
- Jeroen Raes
- Oluf Pedersen
- Karine Clément
- Michael Stumvoll
- Peer Bork
- The MetaCardis Consortium*
short_description: ''
journal: Nature
doi: 10.1038/s41586-021-04177-9
year: 2021
date: 2021-12-8
---

During the transition from a healthy state to cardiometabolic disease, patients
become heavily medicated, which leads to an increasingly aberrant gut
microbiome and serum metabolome, and complicates biomarker discovery.
Here, through integrated multi-omics analyses of 2,173 European residents from
the MetaCardis cohort, we show that the explanatory power of drugs for the
variability in both host and gut microbiome features exceeds that of disease.
We quantify inferred effects of single medications, their combinations as well
as additive effects, and show that the latter shift the metabolome and
microbiome towards a healthier state, exemplified in synergistic reduction in
serum atherogenic lipoproteins by statins combined with aspirin, or enrichment
of intestinal Roseburia by diuretic agents combined with beta-blockers. Several
antibiotics exhibit a quantitative relationship between the number of courses
prescribed and progression towards a microbiome state that is associated with
the severity of cardiometabolic disease. We also report a relationship between
cardiometabolic drug dosage, improvement in clinical markers and microbiome
composition, supporting direct drug effects. Taken together, our computational
framework and resulting resources enable the disentanglement of the effects of
drugs and disease on host and microbiome features in multimedicated
individuals. Furthermore, the robust signatures identified using our framework
provide new hypotheses for drug–host–microbiome interactions in cardiometabolic
disease.


